六月 2026
eskag.in
显示 Similarweb 估计数据。
关联 GA4，公开验证您的网站指标
与您的成功同步
绑定 Google Analytics，验证您网站的流量及用户参与度指标
跳出率
41.92%
每次访问页数
1.69
平均访问时长
00:00:31
- 行业
- 不适用
eskag.in的 10 大竞争对手
在 六月 2026 与 eskag.in 相似的前 10 名网站，按关键字流量、受众定位和市场重叠方面与 eskag.in 的关联性排名
跳出率
23.29%
每次访问页数
3.38
平均访问时长
00:01:01
Jesteśmy polskim producentem leków, suplementów diety oraz preparatów na rynek apteczny i pozaapteczny. Nasze marki to m.in.: IBUM, DIH, Ulgix czy NaturKaps.
跳出率
48.47%
每次访问页数
1.80
平均访问时长
00:00:27
Patients with high-risk, non-muscle invasive bladder cancer now have greater access to the first and only FDA-approved intravesical gene therapy With full supply of ADSTILADRIN ahead of schedule, Ferring ends the temporary ADSTILADRIN Early Experience Program Enrollment in ABLE-41 U.S. Real-World Evidence Study is ongoing Parsippany, NJ – January 16, 2024 – Ferring Pharmaceuticals today announced that ADSTILADRIN® (nadofaragene firadenovec-vncg) …
- 公司
- - -
- 行业
- - -
跳出率
45.61%
每次访问页数
1.72
平均访问时长
00:00:42
Tratamento de diversas infecções, causadas por agentes sensíveis à doxiciclina, tais como febre das montanhas rochosas, febre tifoide, febre Q, varíola, febre do carrapato, infecção do trato respiratório, infecção urinária, sífilis, gonorréia e clamídia.
跳出率
60.21%
每次访问页数
1.57
平均访问时长
00:00:28
Per i 50 anni della rivista, Massimo Di Martino risponde a Medico e Paziente: “Quanto è importante oggi la comunicazione di contenuti scientifici veicolati attraverso una rivista cartacea? Nell’era di internet e dei social media, c’è ancora spazio per le riviste cartacee di aggiornamento clinico? Ci sono punti di forza o aspetti distintivi?” Clicca qui...
跳出率
47.43%
每次访问页数
2.66
平均访问时长
00:01:29
相似度评分
92%drug international limited was incorporated under the registrar of joint stock companies in 1974 as a private limited company. the company commenced formulation and production in 1983 and emerged as a pioneer in bangladesh for adding a state of the art oral solid dosage plant. since inception, drug international limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the world health organization good manufacturing practices (who cgmp) guidelines.
跳出率
27.85%
每次访问页数
3.61
平均访问时长
00:00:57
Virtual tour generated by Panotour
- 公司
- - -
- 行业
- - -
全球排名
#2,208,705
635,912国家/地区排名
#25,652
3,151品类排名
- -
跳出率
39.43%
每次访问页数
1.81
平均访问时长
00:00:38
Vitabalans Oy is a Finnish pharmaceutical company that develops, manufactures and markets prescription medicines.
跳出率
47.55%
每次访问页数
1.89
平均访问时长
00:00:50
A specialized website for doctors, pharmacists, pharmacists and other medical and pharmaceutical professionals.
- 公司
- - -
- 行业
- - -
跳出率
29.54%
每次访问页数
4.20
平均访问时长
00:05:50
相似度评分
86%eskag.in在 六月 2026 的前五名竞争对手是：indoco.com、wallacepharma.com、hasco-lek.pl、ferringusa.com等。
根据 Similarweb 的月访问量数据，eskag.in 在 六月 2026 的头号竞争对手是 indoco.com。与 eskag.in 相似度排名第二的网站是 wallacepharma.com，排名第三的是 hasco-lek.pl。
在 六月 2026，ferringusa.com 被评为与 eskag.in 相似度第四高的网站，pharlab.com.br 位居第五。
进入前十名榜单的其他五家竞争对手分别是 abiogen.it、drug-international.com、polpharma-santo.com、vitabalans.fi 和 arterium.ua。